APA policy prohibits an author from submitting the same manuscript for concurrent consideration by two or more publications. In addition, it is a violation of APA Ethical Principles to publish "as original data, data that have been previously published" (Standard 8.13). As this journal is a primary journal that publishes original material only, APA policy prohibits as well publication of any manuscript that has already been published in whole or substantial part elsewhere.
Authors have an obligation to inform journal editors in their cover letter that the manuscript is not under review elsewhere, that the primary data have not been published previously or accepted for publication, and that the appropriate ethical guidelines were followed in the conduct of the research. However, the editors of GSJP will make an exception for Brief Reports submitted regarding empirical research articles that are under review for publication elsewhere.
In addition, APA Ethical Principles specify that "after research results are published, psychologists do not withhold the data on which their conclusions are based from other competent professionals who seek to verify the substantive claims through reanalysis and who intend to use such data only for that purpose, provided that the confidentiality of the participants can be protected and unless legal rights concerning proprietary data preclude their release" (Standard 8.14). APA expects authors submitting to this journal to adhere to these standards. Specifically, authors are expected to have available their data throughout the editorial review process and for at least 5 years after the date of publication.
Authors will be required to state in writing that they have complied with APA ethical standards in the treatment of their sample, human or animal, or to describe the details of treatment. A copy of the APA Ethical Principles may be obtained electronically or by writing the APA Ethics Office, 750 First Street, NE, Washington, DC 20002-4242. In addition, GSJP requires authors to reveal any possible conflict of interest in the conduct and reporting of research (e.g., financial interests in a test or procedure, funding by pharmaceutical companies for drug research).